|
FUT10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.87020465359478E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59792187762287E-14 |
| Normal-vs-Stage2 |
1.52739999981222E-07 |
| Normal-vs-Stage3 |
1.05330189015262E-11 |
| Normal-vs-Stage4 |
4.93638463439083E-12 |
| Stage1-vs-Stage2 |
9.084400E-01 |
| Stage1-vs-Stage3 |
5.904400E-01 |
| Stage1-vs-Stage4 |
2.390300E-02 |
| Stage2-vs-Stage3 |
6.445400E-01 |
| Stage2-vs-Stage4 |
1.108780E-01 |
| Stage3-vs-Stage4 |
1.434980E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4432899320127E-15 |
| Normal-vs-AfricanAmerican |
1.8797999999931E-06 |
| Normal-vs-Asian |
1.39570000001754E-08 |
| Caucasian-vs-AfricanAmerican |
5.512200E-01 |
| Caucasian-vs-Asian |
8.798000E-01 |
| AfricanAmerican-vs-Asian |
4.988600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8375301280571E-12 |
| Normal-vs-Female |
1.22600041230214E-10 |
| Male-vs-Female |
9.586600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.3970005414451E-10 |
| Normal-vs-Age(41-60Yrs) |
2.75335310107039E-14 |
| Normal-vs-Age(61-80Yrs) |
1.23679955166267E-10 |
| Normal-vs-Age(81-100Yrs) |
2.217100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.079000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.767800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.555400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.759400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.503400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.787000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.878100E-02 |
| Classical-VS-Follicular |
4.120800E-01 |
| Classical-VS-Other |
4.007400E-01 |
| Classical-VS-Normal |
2.16200002345346E-09 |
| Tall-VS-Follicular |
5.081200E-01 |
| Tall-VS-Other |
8.055600E-01 |
| Tall-VS-Normal |
3.23799986823303E-10 |
| Follicular-VS-Other |
6.707200E-01 |
| Follicular-VS-Normal |
9.37629973662979E-10 |
| Other-VS-Normal |
1.642430E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.76587649952853E-13 |
| Normal-vs-N1 |
5.51447776331315E-13 |
| N0-vs-N1 |
5.459500E-03 |
|
|
